Cite
Cohen MR, Smetzer JL. ISMP Medication Error Report Analysis: Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations Hydroxyzine-Hydroxyurea Mix-up Concomitant Use of Entresto and ACE Inhibitors Can Lead to Serious Outcomes More Outpatient Oral Cancer Drugs Should Be in Blister Packs. Hosp Pharm. 2017;52(4):249-252doi: 10.1310/hpj5204-249.
Cohen, M. R., & Smetzer, J. L. (2017). ISMP Medication Error Report Analysis: Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations Hydroxyzine-Hydroxyurea Mix-up Concomitant Use of Entresto and ACE Inhibitors Can Lead to Serious Outcomes More Outpatient Oral Cancer Drugs Should Be in Blister Packs. Hospital pharmacy, 52(4), 249-252. https://doi.org/10.1310/hpj5204-249
Cohen, Michael R, and Smetzer, Judy L. "ISMP Medication Error Report Analysis: Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations Hydroxyzine-Hydroxyurea Mix-up Concomitant Use of Entresto and ACE Inhibitors Can Lead to Serious Outcomes More Outpatient Oral Cancer Drugs Should Be in Blister Packs." Hospital pharmacy vol. 52,4 (2017): 249-252. doi: https://doi.org/10.1310/hpj5204-249
Cohen MR, Smetzer JL. ISMP Medication Error Report Analysis: Potential Issues with New Basal Insulin/GLP-1 Fixed Combinations Hydroxyzine-Hydroxyurea Mix-up Concomitant Use of Entresto and ACE Inhibitors Can Lead to Serious Outcomes More Outpatient Oral Cancer Drugs Should Be in Blister Packs. Hosp Pharm. 2017 Apr;52(4):249-252. doi: 10.1310/hpj5204-249. PMID: 28515501; PMCID: PMC5424826.
Copy
Download .nbib